Safety and Immunogenicity of Intradermal, and Low-Dose Subcutaneous vs Subcutaneous Administration of Menomune- A/C/Y/W-135.
Phase of Trial: Phase IV
Latest Information Update: 09 Dec 2009
At a glance
- Drugs Meningococcal vaccine groups A C Y W-135 polysaccharide; Meningococcal vaccine groups A C Y W-135 polysaccharide
- Indications Meningococcal group A infections; Meningococcal group C infections; Meningococcal group W-135 infections; Meningococcal group Y infections; Meningococcal infections
- Focus Adverse reactions; Pharmacodynamics
- Sponsors Sanofi
- 01 May 2009 Primary endpoints added as reported by ClinicalTrials.gov.
- 26 Feb 2009 New trial record